UAMS Winthrop P. Rockefeller Cancer Instiute

August 25, 2021

NIH Awards UAMS’ Nakagawa $3.6 Million to Expand HPV Cancer Vaccine Study

Marty Trieschmann

Dr. Mayumi Nakagawa - With an additional $3.6 million from the National Institutes of Health, Mayumi Nakagawa's, M.D., Ph.D., ground-breaking HPV vaccine research tops $10 million.

Mayumi Nakagawa, M.D., Ph.D., was awarded $3.6 million from the National Cancer Institute (NCI) to complete phase 2 clinical trials of PepCan, a breakthrough vaccine she developed at UAMS to treat cancers caused by human papillomavirus (HPV).

October 20, 2016

Patient Searches Nation, Finds Best Cancer Care at UAMS

Katrina Dupins

Don Marshall stands outside the UAMS Radiation Oncology Center where he was treated for prostate cancer last year.

Oct. 20, 2016 | When Don Marshall, 58, was diagnosed with prostate cancer, he wanted to make sure he received the best possible care. He was considering traveling to California for treatment until he realized there was a state-of-the-art facility in his own backyard. One year ago, Marshall went to a routine physical examination for…

April 27, 2015

UAMS Lung Cancer Specialists to Present Panel Discussion in Hot Springs Village May 11

ChaseYavondaC

LITTLE ROCK – You’re invited to hear about the latest advances in lung cancer research, treatment and prevention at an event featuring specialists from the University of Arkansas for Medical Scientists (UAMS).